Table 1.
Social-demographic and status of people living with HIV in Wuhan, China, 2020 (N=1701)
| Total enrolled HIV/AIDS (n=1701) | COVID-19 (n=11) | Without COVID-19 (n=1690) | |
|---|---|---|---|
| Age | 42.0±14.5 | 53.2±12.8 | 42.0±14.5 |
| Gender | |||
| Male | 1484(87.2%) | 10 (90.9%) | 1474(87.2%) |
| Female | 217 (12.8%) | 1 (9.1%) | 216 (12.8%) |
| Marriage status | |||
| Married | 416 (24.5%) | 4 (36.4%) | 412 (24.4%) |
| Unmarried | 854 (50.2%) | 4 (36.4%) | 850 (50.3%) |
| Widow | 431 (25.3%) | 3 (27.3%) | 428 (25.3%) |
| Transmission route | |||
| Homosexual | 1173 (69.0%) | 10 (90.9%) | 1163 (68.8%) |
| Heterosexual | 495 (29.1%) | 1 (9.1%) | 494 (29.2%) |
| Others | 33 (1.9%) | 0 (0.0%) | 33 (2.0%) |
| Log10(CD4)* | 2.63±0.31 | 2.50±0.42 | 2.63±0.31 |
| Log10(VL)* | 0.89±1.62 | 0.41±1.37 | 0.89±1.62 |
| Days diagnosed/100 | 16.8±11.8 | 27.4±11.4 | 16.8±11.7 |
| Days ART/100 | 14.5±10.4 | 20.3±10.4 | 14.5±10.4 |
| ART regimen | |||
| NRTI+NNRTI | 1406(82.7%) | 9 (81.8%) | 1397(82.7%) |
| LPV/r-based | 172 (10.1%) | 1 (9.1%) | 171 (10.1%) |
| INI-based | 87 (5.1%) | 0 (0.0%) | 87 (5.1%) |
| None | 36 (2.1%) | 1 (9.1%) | 35 (2.1%) |
Note:
*
Most recent, INI: integrase inhibitors; INI-based: 62 Dolutegravir-based, 19 Elvitegravir/Cobicista-based, 4 Raltegravir-based, 2 Bictegravir-based.